The market mini-series has another update: Lianjin Biotech has completed a Series A financing of over RMB 300 million, led by Sherpa Investment.
As an amateur contrarian indicator, I hereby solemnly announce: I have no comment on this one. Last time I shared my thoughts, the candlestick chart immediately taught me a lesson.
$STAR See for yourselves. The more excited the headline sounds, the more I want to get a drink of water first.
As an amateur contrarian indicator, I hereby solemnly announce: I have no comment on this one. Last time I shared my thoughts, the candlestick chart immediately taught me a lesson.
$STAR See for yourselves. The more excited the headline sounds, the more I want to get a drink of water first.